PL2590949T3 - Sposób wytwarzania chinolino-3-karboksyamidów - Google Patents

Sposób wytwarzania chinolino-3-karboksyamidów

Info

Publication number
PL2590949T3
PL2590949T3 PL11732421T PL11732421T PL2590949T3 PL 2590949 T3 PL2590949 T3 PL 2590949T3 PL 11732421 T PL11732421 T PL 11732421T PL 11732421 T PL11732421 T PL 11732421T PL 2590949 T3 PL2590949 T3 PL 2590949T3
Authority
PL
Poland
Prior art keywords
carboxamides
quinoline
manufacturing
Prior art date
Application number
PL11732421T
Other languages
English (en)
Inventor
Lillemor Maria Bock
Pär Henning Holmberg
Karl-Erik Jansson
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of PL2590949T3 publication Critical patent/PL2590949T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11732421T 2010-07-09 2011-07-07 Sposób wytwarzania chinolino-3-karboksyamidów PL2590949T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36284910P 2010-07-09 2010-07-09
EP10169162 2010-07-09
PCT/EP2011/061490 WO2012004338A1 (en) 2010-07-09 2011-07-07 Method for manufacturing of quinoline-3-carboxamides
EP11732421.0A EP2590949B1 (en) 2010-07-09 2011-07-07 Method for manufacturing of quinoline-3-carboxamides

Publications (1)

Publication Number Publication Date
PL2590949T3 true PL2590949T3 (pl) 2016-06-30

Family

ID=43348982

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11732421T PL2590949T3 (pl) 2010-07-09 2011-07-07 Sposób wytwarzania chinolino-3-karboksyamidów

Country Status (20)

Country Link
US (1) US8871936B2 (pl)
EP (1) EP2590949B1 (pl)
JP (1) JP5881691B2 (pl)
KR (1) KR101855195B1 (pl)
CN (1) CN103119023B (pl)
AU (1) AU2011275720B2 (pl)
BR (1) BR112012033465A2 (pl)
CA (1) CA2802006C (pl)
DK (1) DK2590949T5 (pl)
EA (1) EA021171B1 (pl)
ES (1) ES2563208T3 (pl)
IL (1) IL223583A (pl)
MX (1) MX2013000288A (pl)
NZ (1) NZ604176A (pl)
PL (1) PL2590949T3 (pl)
PT (1) PT2590949E (pl)
SG (1) SG186430A1 (pl)
UA (1) UA108381C2 (pl)
WO (1) WO2012004338A1 (pl)
ZA (1) ZA201209370B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103626701A (zh) * 2012-08-28 2014-03-12 天津药物研究院 一种制备喹啉衍生物的方法
CN103626702A (zh) * 2012-08-30 2014-03-12 天津药物研究院 一种制备喹啉酮衍生物的方法
CN105367492B (zh) * 2014-08-28 2018-07-03 杭州普晒医药科技有限公司 他喹莫德的晶型及其制备方法、其药物组合物和用途
JP6647287B2 (ja) 2014-09-23 2020-02-14 アクティブ バイオテック エイビー 多発性骨髄腫の治療に使用するためのキノリンカルボキサミド
MX379401B (es) 2014-11-19 2025-03-11 Active Biotech Ab Carboxamidas de quinolina para usarse en el tratamiento de leucemia.
KR101807124B1 (ko) * 2015-12-02 2017-12-07 현대자동차 주식회사 연료전지차량의 비상 운전 제어 방법
AU2021229611A1 (en) 2020-03-03 2022-10-27 Active Biotech Ab Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy
CN111732540B (zh) * 2020-07-20 2020-11-13 湖南速博生物技术有限公司 一种罗喹美克的制备方法
BR112023000892A2 (pt) 2020-07-23 2023-02-07 Univ Erasmus Med Ct Rotterdam Inibidor de uma proteína s100 para uso na prevenção ou tratamento de uma neoplasia mieloproliferativa, agente e método para identificar um indivíduo que sofre de uma neoplasia mieloproliferativa, e, métodos para identificar um indivíduo em risco de desenvolver mielofibrose e que se beneficie de um tratamento com um inibidor
ES3057099T3 (en) 2021-01-18 2026-02-26 Active Biotech Ab Tasquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of myelodysplastic syndrome
PL4346773T3 (pl) 2021-05-25 2025-11-03 Active Biotech Ab Duża liczba cząstek taskwinimodu i ich zastosowanie
AU2022303084A1 (en) 2021-07-02 2024-01-25 Active Biotech Ab A pharmaceutical product containing tasquinimod and a method for assessing the purity of said product
KR102815351B1 (ko) 2022-04-20 2025-05-29 국립목포대학교산학협력단 판막 석회화 예방 또는 치료용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769292A (en) * 1972-04-28 1973-10-30 Warner Lambert Co N-(pyridyl)2h 1-benzothiopyran-3-carboxamide-4-hydroxy 1,1-dioxides
US3868379A (en) 1972-04-28 1975-02-25 Warner Lambert Co Heterocyclic amides of 4-hydroxy-2H-1-benzothiopyran-3-carboxylic acid 1,1-dioxide
AT345847B (de) * 1974-11-08 1978-10-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer 4-hydroxy-2h- naphtho- (2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxid und deren salze
US4786644A (en) * 1987-11-27 1988-11-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-quinolinecarboxamide
US5912349A (en) 1997-01-31 1999-06-15 Pharmacia & Upjohn Company Process for the preparation of roquinimex
US6077851A (en) 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9801474D0 (sv) * 1998-04-27 1998-04-27 Active Biotech Ab Quinoline Derivatives
US6133285A (en) 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
SE0201778D0 (sv) * 2002-06-12 2002-06-12 Active Biotech Ab Process for the manufacture of quinoline derivatives
US7560557B2 (en) * 2002-06-12 2009-07-14 Active Biotech Ag Process for the manufacture of quinoline derivatives
US6875869B2 (en) * 2002-06-12 2005-04-05 Active Biotech Ab Process for the manufacture of quinoline derivatives
AU2009215033A1 (en) * 2008-02-15 2009-08-20 Merck Sharp & Dohme Corp. Fused pyridone M1 receptor positive allosteric modulators
WO2009133468A1 (en) * 2008-04-28 2009-11-05 Actavis Group Ptc Ehf Improved process for preparing quinoline-3-carboxamide derivatives

Also Published As

Publication number Publication date
SG186430A1 (en) 2013-01-30
JP5881691B2 (ja) 2016-03-09
AU2011275720A1 (en) 2013-01-10
CA2802006A1 (en) 2012-01-12
CN103119023A (zh) 2013-05-22
BR112012033465A2 (pt) 2017-06-20
MX2013000288A (es) 2013-05-22
EP2590949B1 (en) 2015-11-25
DK2590949T3 (en) 2016-02-29
HK1183864A1 (zh) 2014-01-10
US8871936B2 (en) 2014-10-28
JP2013529672A (ja) 2013-07-22
PT2590949E (pt) 2016-03-07
CN103119023B (zh) 2014-12-24
NZ604176A (en) 2014-10-31
EA021171B1 (ru) 2015-04-30
AU2011275720B2 (en) 2015-05-14
ZA201209370B (en) 2014-03-26
CA2802006C (en) 2018-09-25
IL223583A (en) 2016-03-31
WO2012004338A1 (en) 2012-01-12
KR20130091730A (ko) 2013-08-19
EP2590949A1 (en) 2013-05-15
DK2590949T5 (en) 2016-05-23
UA108381C2 (uk) 2015-04-27
EA201300103A1 (ru) 2013-06-28
ES2563208T3 (es) 2016-03-11
KR101855195B1 (ko) 2018-05-08
US20130109860A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
IL248217B (en) A method for the production of inganol-3-englate
ZA201209370B (en) Method for manufacturing of quinoline-3-carboxamides
IL207945A0 (en) Method for the production of carbohydrates
GB201016436D0 (en) Method of making solid beads
ZA201305972B (en) Method for the preparation of biphephos
GB2485831B (en) A method of manufacturing a component
EP2610338A4 (en) PROCESS FOR PRODUCTION OF SUBSTANCE
GB201008900D0 (en) Method of machining
EP2653482A4 (en) PROCESS FOR PRODUCING PSEUDOPOLYROTAXANE
AP3415A (en) Method for manufacturing of naltrexone
EP2557903A4 (en) METHOD FOR PRODUCING AN EXTERNAL LEADER
GB201007454D0 (en) Method of determining tolerance
PL2476684T3 (pl) Sposób wytwarzania alkilofosforanów
GB201006348D0 (en) Method of manufacturing a component
GB201012784D0 (en) Method
PL2476685T3 (pl) Sposób wytwarzania alkilofosforanów
GB201114798D0 (en) Method of modifying surfaces
EP2586774A4 (en) PROCESS FOR THE PREPARATION OF RANOLAZINE
GB201119607D0 (en) Method of manufacture
PL2476686T3 (pl) Sposób wytwarzania alkilofosforanów
GB201102475D0 (en) Method of reducing offset
PL389965A1 (pl) Sposób wytwarzania 3ß - hydroksy-17 a-oxa-D-homo-5α-androst-17-onu
EP2496096A4 (en) PROCESS FOR PRODUCING MAGNOLIIDAE COMPOUNDS
GB201004059D0 (en) Method of construction
PL395623A1 (pl) Sposób wytwarzania 3-podstawionych cykloalk-2-enonów